ES2106874T3 - Inhibicion de metastasis en pacientes que padecen un cancer con la ayuda de piridiniloxazol-2-onas. - Google Patents

Inhibicion de metastasis en pacientes que padecen un cancer con la ayuda de piridiniloxazol-2-onas.

Info

Publication number
ES2106874T3
ES2106874T3 ES92913637T ES92913637T ES2106874T3 ES 2106874 T3 ES2106874 T3 ES 2106874T3 ES 92913637 T ES92913637 T ES 92913637T ES 92913637 T ES92913637 T ES 92913637T ES 2106874 T3 ES2106874 T3 ES 2106874T3
Authority
ES
Spain
Prior art keywords
cancer
patients
metastasis
piridiniloxazol
onas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92913637T
Other languages
English (en)
Inventor
Alan J Bitonti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2106874T3 publication Critical patent/ES2106874T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ESTE INVENTO TIENE POR OBJETIVO PIRIDINILOXAZOLA AS QUE SON UTILES EN LA INHIBICION DE METASTASIS EN PACIENTES CON CANCER. LAS PIRIDINILOXAZOLA CIENTES CON CANCER.
ES92913637T 1991-05-14 1992-04-14 Inhibicion de metastasis en pacientes que padecen un cancer con la ayuda de piridiniloxazol-2-onas. Expired - Lifetime ES2106874T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69982191A 1991-05-14 1991-05-14

Publications (1)

Publication Number Publication Date
ES2106874T3 true ES2106874T3 (es) 1997-11-16

Family

ID=24811050

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92913637T Expired - Lifetime ES2106874T3 (es) 1991-05-14 1992-04-14 Inhibicion de metastasis en pacientes que padecen un cancer con la ayuda de piridiniloxazol-2-onas.

Country Status (12)

Country Link
US (1) US5610171A (es)
EP (1) EP0539575B1 (es)
AT (1) ATE155686T1 (es)
AU (1) AU645217B2 (es)
CA (1) CA2087334A1 (es)
DE (1) DE69221069T2 (es)
DK (1) DK0539575T3 (es)
ES (1) ES2106874T3 (es)
GR (1) GR3024832T3 (es)
IE (1) IE921524A1 (es)
NZ (1) NZ242677A (es)
WO (1) WO1992020337A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070009529A1 (en) * 2002-03-26 2007-01-11 New York University Agents that dissolve arterial thrombi
US8753631B2 (en) * 2009-05-01 2014-06-17 New York University Therapeutic agents for inducing platelet fragmentation and treating thromboembolic disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935902A1 (de) * 1979-09-05 1981-04-02 A. Nattermann & Cie GmbH, 5000 Köln Oxazolinalkansaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende arzneimittel
US4698353A (en) * 1985-11-13 1987-10-06 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclic oxazolones
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
DE3827974A1 (de) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
ZA908852B (en) * 1989-11-13 1991-09-25 Merrell Dow Pharma Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones
US5182293A (en) * 1989-11-13 1993-01-26 Merrell Dow Pharmaceuticals Inc. Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones

Also Published As

Publication number Publication date
DK0539575T3 (da) 1997-10-27
DE69221069T2 (de) 1997-11-13
GR3024832T3 (en) 1998-01-30
DE69221069D1 (de) 1997-08-28
CA2087334A1 (en) 1992-11-15
IE921524A1 (en) 1992-11-18
US5610171A (en) 1997-03-11
EP0539575B1 (en) 1997-07-23
NZ242677A (en) 1997-06-24
EP0539575A1 (en) 1993-05-05
ATE155686T1 (de) 1997-08-15
AU2167692A (en) 1992-12-30
AU645217B2 (en) 1994-01-06
WO1992020337A2 (en) 1992-11-26
WO1992020337A3 (en) 1993-01-21

Similar Documents

Publication Publication Date Title
TR199701056T1 (xx) Farnesil-protein transferaz enzimi inhibit�rleri.
FI941580A0 (fi) Bisyklisiä ansamysiinejä
NO982034D0 (no) Overf÷ringsbestandige kosmetiske preparater
DK0705100T3 (da) Terapeutiske substituerede guanidiner
DE68902572D1 (de) Maskieren des geschmacks des thymols.
DE69620161D1 (de) Thrombininhibitoren
ATE164593T1 (de) Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
DK0827537T3 (da) Chromatin-regulator-gener
MX9205875A (es) Compuestos.
FR2686425B1 (fr) Source sismique de puits.
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
NO940771L (no) Kollagenfremkalt blodplateaggregeringsinhibitor
ES2106874T3 (es) Inhibicion de metastasis en pacientes que padecen un cancer con la ayuda de piridiniloxazol-2-onas.
MX9202985A (es) Copoliadipamida que contiene unidades de trimetilhexametilenadipamida.
BG97168A (bg) Брадикинин-антагонисти за лечение на остър панкреатит
JO1654B1 (en) The pioneer of the water scale
FR2773078B1 (fr) Utilisation de peptides citrullines derives de la filaggrine pour le traitement de la polyarthrite rhumatoide
SE9100950L (sv) Vvs-armatur foer tvaettstaell
SE9103040L (sv) Saekerhetsfodral
GR1001368B (el) Φαρμακευτικοί φορείς.
KR930008955U (ko) 난간동자의 용접부 은폐커버
FI913696A (fi) Anordning foer styrning instrumenten i en tandvaordsenhet.
FI953464A (fi) Kurpitsan käyttö
ITRM950210A0 (it) Miscela componenti naturali per applicazioni esterne con effetto anticellulitico ed antiflogistico.
NO912174D0 (no) Vandring av seismiske vendeboelger.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 539575

Country of ref document: ES